Adrafinil is currently an unregulated compound in the United States. It is not classified as a controlled substance under the Controlled Substances Act, which distinguishes it from Modafinil, its metabolic successor, which is a Schedule IV prescription medication.
Given the scarcity and the health risks associated with the metabolism of Adrafinil, many have turned to safer, well-researched methods for managing wakefulness and cognitive focus: where can i buy adrafinil in the us
Combinations such as caffeine and L-theanine are widely available and have a more established profile for supporting alertness without the specific liver concerns associated with Adrafinil. Adrafinil is currently an unregulated compound in the
However, Adrafinil is not approved by the Food and Drug Administration (FDA) for any medical use. Because it does not meet the criteria for a dietary supplement, it cannot be legally marketed or sold as one. This lack of oversight means that any product labeled as Adrafinil has not undergone the rigorous testing for safety, purity, or efficacy required of approved pharmaceuticals. Manufacturing and Availability However, Adrafinil is not approved by the Food
The primary reason Adrafinil has largely disappeared from the US market is a halt in production by major global manufacturers. Most reputable domestic nootropic vendors have discontinued sales because they can no longer source raw materials that meet safety and purity standards.